The American Orthotic and Prosthetic Association (AOPA) is pleased to announce the appointment of Dr. Andreas Kannenberg as Health Care Director to the AOPA Board of Directors. This board-appointed position brings valuable healthcare and clinical research expertise to AOPA as we continue to advance initiatives focused on quality care, outcomes measurement, evidence generation, and value-based healthcare.

Dr. Kannenberg has decades of experience at the intersection of medicine, clinical research, healthcare policy, and orthotics and prosthetics (O&P). In his role as Health Care Director, he will provide strategic guidance on AOPA’s efforts to strengthen the profession’s position within the broader healthcare landscape while supporting initiatives that demonstrate the value and impact of O&P care.

“On behalf of the entire Board of Directors, who voted unanimously to appoint him, I am thrilled to welcome Dr. Andreas Kannenberg to AOPA’s leadership team,” said Kimberly Hanson, AOPA President. “Andreas is one of the most respected voices in our profession when it comes to clinical research, outcomes measurement, and demonstrating the value of O&P care. His unique combination of medical expertise, scientific rigor, and healthcare payer experience will be invaluable as AOPA continues to advance initiatives focused on quality, data, and evidence-based patient care. We are excited about the perspective and leadership he will bring to AOPA.”

As AOPA continues to prioritize initiatives that demonstrate clinical outcomes, support quality patient care, and strengthen the profession’s position with policymakers and payers, Dr. Kannenberg’s expertise will help guide the association’s strategic efforts and ensure that data-driven decision-making remains at the forefront of the profession’s future.

About Dr. Kannenberg: Andreas Kannenberg, MD (GER), PhD, graduated from Charité Medical School at Humboldt University in Berlin and worked as a physician in Germany for more than 10 years. He joined Ottobock in 2003 and has been serving as Executive Medical Director North America since 2013. He coordinates Ottobock´s clinical research in the Americas and provides medical support to negotiations with health care payers in the US and Canada. He was presented AOPA´s Thranhardt Award in 2010, 2023, and 2024, AOPA´s Hamontree Award in 2023, and awarded the Honorary Membership of the American Academy of Orthotists & Prosthetists (AAOP) in 2024.